news roundup
Among other highlights, 59 extensions of indication were recommended in 2016. The extension of the use of a medicine that is already approved in a new therapeutic indication can also offer fresh opportunities for patients, EMA stated.
| advertisment
Smarter risk-based monitoring - the answer is closer than you think. Discover the secrect behind improved trial quality and controlled costs on the industry's first on-demand learning portal filled with thought leadership articles, case studies, and more - all on Almac Clinical University.  CTA: Get the answer now! |
The sponsor is using the CRO for an upcoming Phase III gene therapy study.
The agreements for TrialOne were made with Xiyuan Hospital, the Chinese Anti-Cancer Association (CACA) and eStart Medical Technology Co., Ltd.
In this first update of the year, this is the latest business office openings, awards and people moves in the industry.
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
| advertisment
Are Local IRBs Really Necessary?
Live Webinar: Tuesday, February 28 at 1:00pm EST
 Register now |
|
Articles
IRBs are proactively implementing more efficient processes and technologies to streamline ethical review and oversight and nurture stronger relationships with their investigative sites.
Healthcare organizations face demand for data to solve some of the industry's most challenging problems, including research around improving healthcare outcomes and cutting unnecessary costs. Is it possible to strike a balance between the right to privacy and the need to access data?
|
|
Blog Posts
What if we had a clearinghouse of matching services, a Travelocity for clinical trials? The solution must involve technologies and data sources that are aligned to the patient and physician, offering tailored information and services that guide each party through the process and onto the best result for the patient.
An examination of where CROs are going by looking at QuintilesIMS latest financials and acquisitions.
|
|
|
RBM
As companies' scale RBM, clinical quality departments are starting to voice how risk management should be executed.
|
|
This exploratory case study illustrates how RBM can be applied using a specific technology solution from Algorics and examines both data-driven models and centralized manual data review.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
